01
Established in 2018 by father and son duo Michael and Frederik Andreasen and joint forces in 2019 with MSG Capital aps. Valeos Pharma is a testament to the power of compassion and innovation in Phyto Pharmaceuticals.
02
With a mission at Valeos Pharma A/S, to pioneer the production of high-quality medicinal cannabis under stringent Good Manufacturing Practices (GMP) standards. Through our Danish-based operations, we are committed to harnessing the therapeutic potential of cannabis to improve the lives of patients globally. We strive to cultivate, innovate, and collaborate to deliver safe, reliable, and effective medicinal cannabis products, prioritizing patient well-being and scientific advancement.
03
And a vision to be among the leading forces in the medicinal cannabis industry, recognized for our unwavering dedication to excellence, innovation, and ethical practices. We aspire to shape the future of medical cannabis by advancing research, cultivating unique strains, and setting new benchmarks for quality and safety. By combining Danish agricultural precision with a deep-rooted commitment to healthcare, we aim to empower patients and healthcare professionals with reliable access to standardized, GMP-compliant medicinal cannabis.